Premium
The cyclopentenone prostaglandin 15‐deoxy‐Δ 12,14 ‐ PGJ 2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat
Author(s) -
Cuzzocrea Salvatore,
Ianaro Angela,
Wayman Nicole S,
Mazzon Emanuela,
Pisano Barbara,
Dugo Laura,
Serraino Ivana,
Di Paola Rosanna,
Chatterjee Prabal K,
Di Rosa Massimo,
Caputi Achille P,
Thiemermann Christoph
Publication year - 2003
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0705077
Subject(s) - nitrotyrosine , nitric oxide synthase , chemistry , colitis , myeloperoxidase , malondialdehyde , prostaglandin , inflammation , nitric oxide , pharmacology , biochemistry , endocrinology , medicine , oxidative stress , biology , enzyme
Inflammatory bowel disease (IBD) is characterized by oxidative and nitrosative stress, leukocyte infiltration, and increased expression of the adhesion molecules intercellular adhesion molecule 1 (ICAM‐1) in the colon. Recent evidence also suggests that the cyclopentenone prostaglandin (PG) 15‐deoxy‐Δ 12,14 ‐PGJ 2 (15d‐ PGJ 2 ) functions as an early anti‐inflammatory signal. The aim of the present paper is to investigate the effects of 15d‐PGJ 2 in rats subjected to experimental colitis. Colitis was induced in rats by intra‐colonic instillation of dinitrobenzene sulphonic acid (DNBS). 15d‐PGJ 2 was administered daily as intraperitoneal injection (20 or 40 μg kg −1 ). On day 4, animals were sacrificed and tissues were taken for histological and biochemical analysis. 15d‐PGJ 2 significantly reduced the degree of haemorrhagic diarrhoea and weight loss caused by administration of DNBS. 15d‐PGJ 2 also caused a substantial reduction of (i) the degree of colonic injury, (ii) the rise in myeloperoxidase (MPO) activity (mucosa), (iii) the increase in the tissue levels of malondialdehyde (MDA) and (iv) of the pro‐inflammatory cytokines tumour necrosis factor‐alpha (TNF‐α) and interleukin‐1β (IL‐1β). Furthermore, 15d‐PGJ 2 reduced the increase in immunohistochemical staining for (i) inducible nitric oxide synthase (iNOS), (ii) nitrotyrosine and (iii) poly (ADP‐ribose) polymerase (PARP), as well as (iv) the increased expression of ICAM‐1 caused by DNBS in the colon. Electrophoresis mobility shift assay (EMSA) of inflamed colon revealed that 15d‐ PGJ 2 also caused a substantial reduction of the activation of nuclear factor‐kappaB (NF‐κB). Furthermore, 15d‐PGJ 2 stimulates the activation of heat shock protein 72 ( hsp72 ) in the inflamed colon, as assessed by Western blot analysis. In conclusion, 15d‐PGJ 2 reduces the development of experimental colitis.British Journal of Pharmacology (2003) 138 , 678–688. doi: 10.1038/sj.bjp.0705077